| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年7月 |
Pharmaceutical Excipients Market – Global Forecast To 2030
この調査レポートでは、医薬品添加剤市場を製品別（有機（油脂化学品、炭水化物、石油化学品、タンパク質、その他の有機化学品）、無機（リン酸カルシウム、金属酸化物、岩塩、炭酸カルシウム、硫酸カルシウム、その他の無機化学品）、その他の化学品）、機能性別（充填剤および希釈剤、懸濁剤および粘稠剤、コーティング剤、結合剤、香料および甘味料、崩壊剤、着色料、滑沢剤および流動促進剤、防腐剤、乳化剤、その他の機能性）、処方別（経口（錠剤、カプセル、液状製剤およびその他の経口製剤）、局所製剤、非経口製剤およびその他の製剤）、機能性用途別（安定剤、風味付与、放出制御、溶解性およびバイオアベイラビリティ向上）に分類しています。 （およびその他の機能アプリケーション）、および地域（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）別に分析します。
本レポートは、医薬品添加剤市場の成長に影響を与える主要な要因（促進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、事業概要、製品、ソリューション、主要戦略、提携、パートナーシップ、契約に関する洞察を提供しています。医薬品添加剤市場に関連する新規承認／発売、提携、買収、最近の動向についても取り上げています。
The global pharmaceutical excipients market is projected to reach USD 14.86 billion by 2030 from USD 11.03 billion in 2025, at a CAGR of 6.1% during the forecast period. The expansion of the Pharmaceutical Excipients market has been predominantly driven by the Surging demand for pharmaceutical products and generic medicines, and R&D investments for novel excipient development are predicted to uplift the market in the coming years. Additionally, partnerships and collaboration with pharmaceutical companies and increased emphasis on patient-centric formulations will provide lucrative market growth opportunities. However, regulatory stringency and steep development costs are predicted to restrict the market.
世界の医薬品添加剤市場は、2025年の110億3,000万米ドルから2030年には148億6,000万米ドルに達し、予測期間中は年平均成長率（CAGR）6.1%で成長すると予測されています。医薬品添加剤市場の拡大は、主に医薬品およびジェネリック医薬品の需要の急増によって牽引されており、今後数年間は新規添加剤開発への研究開発投資が市場を押し上げると予測されています。さらに、製薬企業との提携や協業、そして患者中心の処方への注力の高まりが、市場の成長機会の拡大につながると予想されます。しかしながら、規制の厳格化と開発コストの高騰が市場の成長を阻害すると予測されています。
List of Key Companies Profiled in the Report
Key players in the pharmaceutical excipients market include International Flavors & Fragrances Inc. (US), Ashland Inc. (US), Evonik Industries AG (Germany), BASF SE (Germany), Kerry Group plc (Ireland), Roquette Frères (France), MERCK KGaA (Germany), Associated British Foods plc (UK), ADM (US), Wacker Chemie AG (Germany), Air Liquide (France), DOW (US), Berkshire Hathaway Inc. (US), Colorcon (US), DFE PHARMA (Germany), Actylis (US), Croda International Plc(UK), Chemie Trade(India), Gattefossé (France), JRS Pharma(US), and Shin-Etsu Chemical Co., Ltd. (Japan).
pharma-excipients-market-Ecosystem
Reasons to Buy this Report
The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical excipients market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (Surging demand for generic medications and pharmaceutical formulations, Increased R&D investments to develop novel excipients, A growing focus on patient-centric drug formulations, Strategic collaborations and partnerships with pharmaceutical firms), restraints (Strict and complex regulatory frameworks, High costs associated with excipient development and manufacturing), opportunities (Increasing interest in functional and multifunctional excipients, Technological advancements, particularly in nanotechnology, Expansion into emerging economies across Asia Pacific and Latin America), and Challenges (Ongoing concerns about excipient safety and quality standards, Limited availability and fluctuating costs of key raw materials).
- Product Development/Innovation: Detailed insights on upcoming products, research and development activities, and new product approvals/launches in the Pharmaceutical Excipients market.
- Market Development: Comprehensive information about lucrative markets; the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical excipients market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the pharmaceutical excipients market.